Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis

Journal of Investigative Dermatology

Volumn 107, Issue 1, 1996, Pages 51-56

  Hanifin, Jon M ^a   Chan, Sai C ^a   Cheng, John B ^b   Tofte, Susan J ^a   Henderson Jr , William R ^c   Kirby, Deborah S ^b   Weiner, Ethan S ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

IL 10; Monocytes; PDE IL 4

Indexed keywords

4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; ATIZORAM; CP 102995; CP 76593; INTERLEUKIN 10; INTERLEUKIN 4; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MALE; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0030056483     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12297888     Document Type: Article

References (22)

1. Beavo JA: Multiple isozymes of cyclic nucleotide phosphodiesterase. Adv Cyc Nuc Res 22:1-38, 1988
2. Beavo JA: In: Beavo J, Houslay MD (eds.). Cyclic Nucleotide Phosphodiesterases: Structure, Regulation and Drug Action. Multiple Phosphodiesterase Isoenzymes: Background, Nomenclature and Implications. John Wiley & Son, New York, 1990, pp 3-15
3. Butler JM, Chan SC, Stevens SR, Hanifin JM: Increased leukocyte histamine release with elevated cyclic AMP-phosphodiesterase activity in atopic dermatitis. J Allergy Clin Immunol 71:490-497, 1983
4. Chan SC, Hanifin JM: Differential inhibitor effects on cyclic AMP phosphodiesterase isoforms in atopic and normal leukocytes. J Lab Clinn Med 121:44-51, 1993
5. 2 regulation of cytokine production in atopic dermatitis. J Immunol 151:3345-3352, 1993
6. IV) inhibitor, CP80,633. J Allergy Clin Immunol 95:350, 1995
7. Cooper KD, Kang KF, Chan SC, Hanifin JM: Phosphodiesterase inhibition by Ro 20-1724 reduces hyper-IgE synthesis by atopic dermatitis cells in vitro. J Invest Dermatol 84:477-482, 1985
8. Geissler FT, Kuzan FB, Faustman EM, Henderson WR, Jr.: Lipid mediator production by post-implantation rat embryos in vitro. Prostaglandins 38:145-155, 1989
9. Giustina TA, Chan SC, Baker JW, Hanifin JM: Increased leukocyte sensitivity to PDE inhibitors in atopic dermatitis: tachyphylaxis after theophylline therapy. J Allergy Clin Immunol 74:252-257, 1984
10. Grewe S, Chan SC, Hanifin JM: Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP-agonist hyporesponsiveness. J Allergy Clin Immunol 70:452-457, 1982
11. Hanifin JM, Rajka G: Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl 92:44-47, 1980
12. Heskel NS, Chan SC, Thiel ML, Stevens SR, Casperson LS, Hanifin JM: Elevated umbilical cord blood leukocyte cyclic adenosine monophosphate-phosphodiesterase activity in children with atopic parents. J Am Acad Dermatol 11:422-426, 1984
13. Jaffe BM, Behrman HR (eds.): Hormone Radioimmunoassay. Prostaglandius E, A, and F. Academic Press, New York, 1974, p 19
14. Lapidus CS, Schwarz DF, Honig PJ: Atopic dermatitis in children: Who cares? Who pays? J Am Acad Dermatol 28:699-703, 1993
15. Li SH, Chan SC, Toshitani A, Leung DYM, Hanifin JM: Synergistic effects of interleukin 4 and interferon-gamma on monocyte phosphodiesterase activity. J Invest Dermatol 99:65-70, 1993
16. Nassif A, Chan SC, Storrs FJ, and Hanifin JM: Abnormal skin irritancy in atopic dermatitis and in atopy without dermatitis. Arch Dermatol 130:1402-1407, 1994
17. Ohmen JD, Hanifin JM, Nickoloff BJ, Rea TH, Wyzykowski R, Kim J, Jullien D, McHugh T, Nassif AS, Chan SC, Modlin RL: Overexpression of IL-10 in atopic dermatitis: contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 154:1956-1963, 1995
18. Sampson HA: Pathogenesis of eczema. Clin Exp Allergy 1990;20:459
19. Shmones E, Keil JE: Occupational dermatoses in South Carolina: a descriptive analysis of cost variables. J Am Acad Dermatol 9:861-866, 1983
20. Szentivanyi A: The beta-adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy 42:203-232, 1968
21. Thompson WJ, Terasaki WL, Epstein PM, Strada SJ: Assay of cyclic nucleotide phosphodiesterase and resolution of multiple molecular form of the enzyme. Adv Cyclic Nucleotide Res 10:69-92, 1979
22. Torphy TJ, Undem BJ: Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 46:512-523, 1991